Working… Menu

Qualitative Research on Women With Congenital Adrenal Hyperplasia (CAH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00559078
Recruitment Status : Completed
First Posted : November 16, 2007
Last Update Posted : November 9, 2009
Information provided by:
Lehigh University

Brief Summary:
This qualitative interview-based study will investigate the impact that living with congenital adrenal hyperplasia has for women in the following areas: health-related quality of life (HRQL), psychological health, and health-seeking behaviors.

Condition or disease Intervention/treatment
Congenital Adrenal Hyperplasia Other: Interview

Detailed Description:
Congenital Adrenal Hyperplasia is a chronic-illness requiring life-long treatment and is caused by an inherited enzyme deficiency that leads to an overproduction of hormones produced by the adrenal glands, which in turn, masculinizes the female genitalia before birth. While the mechanisms by which CAH influences physiological development are understood, the impact of this hormonal elevation on health-related quality of life (HRQL), psychological health, and health-seeking behaviors is less clear. This study is guided by three research questions: (1) how does CAH influence HRQL domains (physical, functional, emotional and interpersonally), (2) how does CAH influence the mental health of women diagnosed with CAH, and (3) how does CAH influence decisions to seek help from a counselor? Semi-structured qualitative interviews will be conducted with women with CAH. Interviews will be analyzed through the Consensual Qualitative Research (CQR) methodology.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 16 participants
Time Perspective: Cross-Sectional
Official Title: Health-related Quality of Life, Mental Health and Psychotherapeutic Considerations for Women Diagnosed With a Disorder of Sexual Development: Congenital Adrenal Hyperplasia
Study Start Date : July 2007
Actual Study Completion Date : May 2009

Group/Cohort Intervention/treatment
Women diagnosed with CAH (either simple virilizing or salt-losing)
Other: Interview
Hour-long, qualitative, phone interview

Primary Outcome Measures :
  1. Telephone interview consisting of approximately 7 open ended questions addressing domains of HRQL, Mental Health and Support [ Time Frame: 1 hour ]

Secondary Outcome Measures :
  1. Demographic Questionnaire [ Time Frame: 15 minutes ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   25 Years to 55 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Women diagnosed with CAH (either simple-virilizing or salt-losing types) living in the United States

Inclusion Criteria:

  • 46XX, Females
  • Diagnosed by a physician with CAH (either simple-virilizing or salt-losing types)
  • Willing to complete a brief demographic questionnaire and participate in an hour long telephone interview

Exclusion Criteria:

  • Non-classical or late-onset CAH

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00559078

Layout table for location information
United States, Pennsylvania
Lehigh University
Bethlehem, Pennsylvania, United States, 18015
Sponsors and Collaborators
Lehigh University
Layout table for investigator information
Study Director: Matthew A Malouf, BA Lehigh University Counseling Psychology
Principal Investigator: Arpana G Inman Lehigh University Counseling Psychology

Layout table for additonal information
Responsible Party: Matthew Malouf, Lehigh University Identifier: NCT00559078     History of Changes
Other Study ID Numbers: 1-Malouf
First Posted: November 16, 2007    Key Record Dates
Last Update Posted: November 9, 2009
Last Verified: November 2009
Keywords provided by Lehigh University:
Adrenal Hyperplasia, Congenital
Psychosexual Development
Sexual Development
Disorder of Sex Development
Quality of Life
Mental Health
Additional relevant MeSH terms:
Layout table for MeSH terms
Adrenal Hyperplasia, Congenital
Adrenogenital Syndrome
Adrenocortical Hyperfunction
Pathologic Processes
Disorders of Sex Development
Urogenital Abnormalities
Congenital Abnormalities
Genetic Diseases, Inborn
Steroid Metabolism, Inborn Errors
Metabolism, Inborn Errors
Metabolic Diseases
Adrenal Gland Diseases
Endocrine System Diseases
Gonadal Disorders
Epinephryl borate
Adrenergic alpha-Agonists
Adrenergic Agonists
Adrenergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs
Adrenergic beta-Agonists
Bronchodilator Agents
Autonomic Agents
Peripheral Nervous System Agents
Anti-Asthmatic Agents
Respiratory System Agents